nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB2—chronic obstructive pulmonary disease	0.4	1	CbGaD
Alprenolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.105	0.18	CbGbCtD
Alprenolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.103	0.178	CbGbCtD
Alprenolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0793	0.137	CbGbCtD
Alprenolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0793	0.137	CbGbCtD
Alprenolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0781	0.135	CbGbCtD
Alprenolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0781	0.135	CbGbCtD
Alprenolol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0199	0.0343	CbGbCtD
Alprenolol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0199	0.0343	CbGbCtD
Alprenolol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0177	0.0306	CbGbCtD
Alprenolol—Metipranolol—ADRB2—chronic obstructive pulmonary disease	0.000559	0.122	CrCbGaD
Alprenolol—Esmolol—ADRB2—chronic obstructive pulmonary disease	0.000444	0.0972	CrCbGaD
Alprenolol—Betaxolol—ADRB2—chronic obstructive pulmonary disease	0.000391	0.0855	CrCbGaD
Alprenolol—Atenolol—ADRB2—chronic obstructive pulmonary disease	0.000388	0.0848	CrCbGaD
Alprenolol—Penbutolol—ADRB2—chronic obstructive pulmonary disease	0.000388	0.0848	CrCbGaD
Alprenolol—Bisoprolol—ADRB2—chronic obstructive pulmonary disease	0.000378	0.0826	CrCbGaD
Alprenolol—Acebutolol—ADRB2—chronic obstructive pulmonary disease	0.000358	0.0782	CrCbGaD
Alprenolol—Oxprenolol—ADRB2—chronic obstructive pulmonary disease	0.000355	0.0777	CrCbGaD
Alprenolol—Betaxolol—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.0707	CrCbGaD
Alprenolol—Metoprolol—ADRB2—chronic obstructive pulmonary disease	0.000302	0.066	CrCbGaD
Alprenolol—Pindolol—ADRB2—chronic obstructive pulmonary disease	0.000279	0.0611	CrCbGaD
Alprenolol—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.0136	CbGpPWpGaD
Alprenolol—ADRB1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000215	0.0136	CbGpPWpGaD
Alprenolol—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.0131	CbGpPWpGaD
Alprenolol—HTR1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000206	0.013	CbGpPWpGaD
Alprenolol—ADRB1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.0002	0.0126	CbGpPWpGaD
Alprenolol—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000196	0.0124	CbGpPWpGaD
Alprenolol—HTR1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000191	0.0121	CbGpPWpGaD
Alprenolol—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.0118	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000177	0.0112	CbGpPWpGaD
Alprenolol—ADRB1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000176	0.0111	CbGpPWpGaD
Alprenolol—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000172	0.0108	CbGpPWpGaD
Alprenolol—ADRB1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000168	0.0106	CbGpPWpGaD
Alprenolol—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000165	0.0104	CbGpPWpGaD
Alprenolol—HTR1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000161	0.0102	CbGpPWpGaD
Alprenolol—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.0101	CbGpPWpGaD
Alprenolol—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.0099	CbGpPWpGaD
Alprenolol—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000152	0.0333	CrCbGaD
Alprenolol—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00952	CbGpPWpGaD
Alprenolol—ADRB3—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.00015	0.00944	CbGpPWpGaD
Alprenolol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.000139	0.0088	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000133	0.00838	CbGpPWpGaD
Alprenolol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.0286	CrCbGaD
Alprenolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000129	0.00815	CbGpPWpGaD
Alprenolol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.0276	CrCbGaD
Alprenolol—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000124	0.00785	CbGpPWpGaD
Alprenolol—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00735	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000114	0.00718	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	9.98e-05	0.0063	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.16e-05	0.00578	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	9.01e-05	0.00569	CbGpPWpGaD
Alprenolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.96e-05	0.00566	CbGpPWpGaD
Alprenolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	8.88e-05	0.0056	CbGpPWpGaD
Alprenolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.84e-05	0.00558	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	8.7e-05	0.00549	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	8.66e-05	0.00546	CbGpPWpGaD
Alprenolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	8.43e-05	0.00532	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.32e-05	0.00525	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	8.12e-05	0.00512	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	7.87e-05	0.00497	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	7.7e-05	0.00486	CbGpPWpGaD
Alprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	7.66e-05	0.00484	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	7.53e-05	0.00476	CbGpPWpGaD
Alprenolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.26e-05	0.00458	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.13e-05	0.0045	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.09e-05	0.00448	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	6.75e-05	0.00426	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	6.6e-05	0.00417	CbGpPWpGaD
Alprenolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.51e-05	0.00411	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.51e-05	0.00411	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	6.45e-05	0.00407	CbGpPWpGaD
Alprenolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.42e-05	0.00406	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.37e-05	0.00402	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	6.24e-05	0.00394	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.07e-05	0.00383	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.57e-05	0.00352	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	5.52e-05	0.00349	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.51e-05	0.00348	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.43e-05	0.00343	CbGpPWpGaD
Alprenolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.28e-05	0.00333	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.14e-05	0.00324	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.03e-05	0.00317	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4.94e-05	0.00312	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.91e-05	0.0031	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.89e-05	0.00309	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.85e-05	0.00306	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4.72e-05	0.00298	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.64e-05	0.00293	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.59e-05	0.0029	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.44e-05	0.0028	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.3e-05	0.00271	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.24e-05	0.00268	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.23e-05	0.00267	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.21e-05	0.00266	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.12e-05	0.0026	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.05e-05	0.00256	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.03e-05	0.00254	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.86e-05	0.00244	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.86e-05	0.00244	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.0024	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.78e-05	0.00239	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.78e-05	0.00238	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.7e-05	0.00234	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.69e-05	0.00233	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.62e-05	0.00228	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.6e-05	0.00227	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.52e-05	0.00222	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.45e-05	0.00218	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.44e-05	0.00217	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.41e-05	0.00215	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.31e-05	0.00209	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.27e-05	0.00207	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.27e-05	0.00207	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.26e-05	0.00206	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.24e-05	0.00204	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.22e-05	0.00203	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.22e-05	0.00203	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.2e-05	0.00202	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.002	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.16e-05	0.002	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.13e-05	0.00198	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.08e-05	0.00195	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.07e-05	0.00194	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.96e-05	0.00187	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.92e-05	0.00184	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.9e-05	0.00183	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.88e-05	0.00182	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.84e-05	0.00179	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.82e-05	0.00178	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.8e-05	0.00177	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.79e-05	0.00176	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.78e-05	0.00175	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.77e-05	0.00175	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.00175	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.75e-05	0.00174	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.74e-05	0.00173	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.64e-05	0.00166	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.62e-05	0.00166	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.62e-05	0.00166	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.58e-05	0.00163	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.55e-05	0.00161	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.52e-05	0.00159	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.00159	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.49e-05	0.00157	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.49e-05	0.00157	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.46e-05	0.00156	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.46e-05	0.00155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.44e-05	0.00154	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.41e-05	0.00152	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.4e-05	0.00151	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.38e-05	0.0015	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.25e-05	0.00142	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.18e-05	0.00138	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.04e-05	0.00129	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2e-05	0.00126	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.96e-05	0.00123	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.93e-05	0.00122	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.92e-05	0.00121	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.92e-05	0.00121	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.89e-05	0.00119	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.85e-05	0.00117	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.82e-05	0.00115	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.78e-05	0.00113	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.74e-05	0.0011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.65e-05	0.00104	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.65e-05	0.00104	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.63e-05	0.00103	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.00101	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.58e-05	0.000999	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.56e-05	0.000983	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.56e-05	0.000983	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000983	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.52e-05	0.000962	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000961	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.000943	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.49e-05	0.000941	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.49e-05	0.00094	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.48e-05	0.000936	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.48e-05	0.000933	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.47e-05	0.000929	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.000917	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.45e-05	0.000913	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.42e-05	0.000899	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.41e-05	0.000893	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.000879	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.36e-05	0.00086	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000853	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.35e-05	0.00085	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.34e-05	0.000844	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.29e-05	0.000816	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.29e-05	0.000812	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.26e-05	0.000799	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.24e-05	0.000781	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.2e-05	0.000755	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.14e-05	0.000719	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.11e-05	0.000703	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.09e-05	0.000688	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.06e-05	0.000668	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.04e-05	0.000654	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.01e-05	0.000639	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.84e-06	0.000621	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.77e-06	0.000617	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.39e-06	0.000593	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.35e-06	0.00059	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.96e-06	0.000566	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.8e-06	0.000555	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.73e-06	0.000551	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.6e-06	0.000543	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.54e-06	0.000539	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.41e-06	0.000531	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.35e-06	0.000527	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.99e-06	0.000504	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.95e-06	0.000502	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.94e-06	0.000501	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.94e-06	0.000501	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.85e-06	0.000495	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.81e-06	0.000493	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.76e-06	0.00049	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.64e-06	0.000482	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.64e-06	0.000482	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.59e-06	0.000479	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.56e-06	0.000477	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.47e-06	0.000472	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.31e-06	0.000461	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.19e-06	0.000454	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.16e-06	0.000452	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.1e-06	0.000448	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.95e-06	0.000439	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.79e-06	0.000429	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.6e-06	0.000416	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.46e-06	0.000408	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.93e-06	0.000374	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.84e-06	0.000369	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.81e-06	0.000367	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.71e-06	0.000361	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.58e-06	0.000353	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.57e-06	0.000352	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.5e-06	0.000347	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.45e-06	0.000344	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.43e-06	0.000343	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.33e-06	0.000336	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.32e-06	0.000336	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.2e-06	0.000329	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.09e-06	0.000321	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.06e-06	0.000319	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.88e-06	0.000308	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.79e-06	0.000303	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.72e-06	0.000298	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.62e-06	0.000291	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.51e-06	0.000285	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.49e-06	0.000283	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.47e-06	0.000282	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.39e-06	0.000277	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.29e-06	0.000271	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.27e-06	0.000269	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.18e-06	0.000264	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.08e-06	0.000258	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.83e-06	0.000242	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.75e-06	0.000237	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-06	0.000231	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.52e-06	0.000222	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.45e-06	0.000218	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.44e-06	0.000217	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.37e-06	0.000213	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.36e-06	0.000212	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.3e-06	0.000208	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.26e-06	0.000206	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.12e-06	0.000197	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.9e-06	0.000183	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.83e-06	0.000179	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.77e-06	0.000175	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.65e-06	0.000167	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.59e-06	0.000164	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.54e-06	0.00016	CbGpPWpGaD
